Hand hygiene, and not ertapenem use, contributed to reduction of carbapenem-resistant Pseudomonas aeruginosa rates

Infection Control and Hospital Epidemiology

Volumn 32, Issue 6, 2011, Pages 584-590

  dos Santos, Rodrigo Pires ^a   Jacoby, Thalita ^a   Machado, Denise Pires ^a   Lisboa, Thiago ^a   Gastal, Sandra Ludwig ^a   Nagel, Fabiano Márcio ^a   Kuplich, Nádia Mora ^a   Konkewicz, Loriane ^a   Lovatto, Carem Gorniak ^a   Pires, Márcia Rosane ^a   Goldani, Luciano Zubaran ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CARBAPENEM; ERTAPENEM; IMIPENEM; MEROPENEM;

ANTIBIOTIC RESISTANCE; ANTISEPSIS; ARTICLE; BRAZIL; HAND WASHING; HUMAN; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION;

ANTI-BACTERIAL AGENTS; BETA-LACTAM RESISTANCE; BETA-LACTAMS; CARBAPENEMS; CROSS INFECTION; HANDWASHING; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; REGRESSION ANALYSIS;

EID: 79957965935     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/660100     Document Type: Article

References (34)

1. Kollef MH. Broad-spectrum antimicrobials and the treatment of serious bacterial infections: getting it right up front. Clin Infect Dis 2008;47(suppl 1):S3-S13.
2. Dellit TH, Owens RC, McGowan JE Jr, et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44: 159-177.
3. Livermore DM, Mushtaq S, Warner M. Selectivity of ertapenem for Pseudomonas aeruginosa mutants cross-resistant to other car-bapenems. J Antimicrob Chemother 2005;55:306-311.
4. Goff DA, Mangino JE. Ertapenem: no effect on aerobic gram-negative susceptibilities to imipenem. J Infect 2008;57:123-127.
5. Lima ALL, Olivera PR, Paula AP, Dal-Paz K, Rossi F, Zumiotti AV. The impact of ertapenem use on the susceptibility of Pseu-domonas aeruginosa to imipenem: a hospital case study. Infect Control Hosp Epidemiol 2009;30:487-490.
6. Goldstein EJ, Citron DM, Peraino V, Elgourt T, Meibohm AR, Lu S. Introduction of ertapenem into a hospital formulary: effect on antimicrobial usage and improved in vitro susceptibility of Pseudomonas aeruginosa. Antimicrob Agents Chemother 2009;53: 5122-5126.
7. Eagye KJ, Nicolau DP. Absence of association between use of ertapenem and change in antipseudomonal carbapenem susceptibility rates in 25 hospitals. Infect Control Hosp Epidemiol 2010;31:485-490.
8. Pagani L. Antimicrobial stewardship: therés no such thing as too much. Am J Respir Crit Care Med 2010;181:94.
9. Natsch S, Hekster YA, de Jong R, Heerdink ER, Herings RM, van der Meer JW. Application of the ATC/DDD methodology to monitor antibiotic drug use. Eur J Clin Microbiol Infect Dis 1998;17:20-24.
10. Edwards JR, Peterson KD, Andrus ML, et al. National Healthcare Safety Network (NHSN) report, data summary for 2006. Am J Infect Control 2007;35:290-301.
11. Hindler JF, Stelling J. Analysis and presentation of cumulative antibiograms: a new consensus guideline from the Clinical and Laboratory Standards Institute. Clin Infect Dis 2007;44:867-873.
12. Clinical Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobi-cally. Approved standard M7-A7. 7th ed. Wayne, PA: CLSI; 2006.
13. Siegel JD, Rhinehart E, Jackson M, Chiarello L. Healthcare infection control management of multidrug-resistant organisms in health care settings, 2006. Am J Infect Control 2007;35(suppl 2):S165-S193.
14. Shardell M, Harris AD, El-Kamary SS, Furuno JP, Miller RR, Perencevich EN. Statistical analysis and application of quasi experiments to antimicrobial resistance intervention studies. Clin Infect Dis 2007;45:901-907.
15. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 2002;27:299-309.
16. Zhang F, Wagner AK, Soumerai SB, Ross-Degnan D. Methods for estimating confidence intervals in interrupted time series analyses of health interventions. J Clin Epidemiol 2009;62:143-148.
17. Falagas ME, Kopterides P. Risk factors for the isolation of multi-drug-resistant Acinetobacter baumannii and Pseudomonas aeru-ginosa: a systematic review of the literature. J Hosp Infect 2006; 64:7-15.
18. Tacconelli E, De Angelis G, Cataldo MA, et al. Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based study. Antimicrob Agents Chemother 2009;53:4264-4269.
19. Lodise TP, Miller CD, Graves J, et al. Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance. Anti-microb Agents Chemother 2007;51:417-422.
20. Lautenbach E, Weiner MG, Nachamkin I, Bilker WB, Sheridan A, Fishman NO. Imipenem resistance among Pseudomonas aeru-ginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes. Infect Control Hosp Epidemiol 2006;27:893-900.
21. Fortaleza CM, Freire MP, Filho DC, de Carvalho Ramos M. Risk factors for recovery of imipenem- or ceftazidime-resistant Pseu-domonas aeruginosa among patients admitted to a teaching hospital in Brazil. Infect Control Hosp Epidemiol 2006;27:901-906.
22. Lodise TP Jr, Miller C, Patel N, Graves J, McNutt LA. Identification of patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk of infection with carbapenem-resistant isolates. Infect Control Hosp Epidemiol 2007;28:959-965.
23. Eagye KJ, Kuti JL, Nicolau DP. Risk factors and outcomes associated with isolation of meropenem high-level-resistant Pseu-domonas aeruginosa. Infect Control Hosp Epidemiol 2009;30:746-752.
24. Carling P, Fung T, Killion A, Terrin N, Barza M. Favorable impact of a multidisciplinary antibiotic management program conducted during 7 years. Infect Control Hosp Epidemiol 2003; 24:699-706.
25. Liebowitz LD, Blunt MC. Modification in prescribing practices for third-generation cephalosporins and ciprofloxacin is associated with a reduction in methicillin-resistant Staphylococcus aureus bacteraemia rate. J Hosp Infect 2008;69:328-336.
26. Pakyz AL, Oinonen M, Polk RE. Relationship of carbapenem restriction in 22 university teaching hospitals to carbapenem use and carbapenem-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 2009;53:1983-1986.
27. Fukushima Y, Fukushima F, Kamiya K, et al. Relation between the antimicrobial susceptibility of clinical isolates of Pseudo-monas aeruginosa from respiratory specimens and antimicrobial use density (AUD) from 2005 through 2008. Intern Med 2010; 49:1333-1340.
28. Pires Dos Santos R, Konkewicz LR, Nagel F, et al. The 2009 H1N1 influenza A pandemic and hand hygiene practices in a hospital in the south of Brazil. Infect Control Hosp Epidemiol 2010;31:1313-1315.
29. Boyce JM, Pittet D. Healthcare Infection Control Practices Advisory Committee. Guideline for hand hygiene in health-care settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/ IDSA Hand Hygiene Task Force. Society for Healthcare Epidemiology of America/Association for Professionals in Infection Control/Infectious Diseases Society of America. MMWR Re-comm Rep 2002;51:1-45.
30. Pittet D, Hugonnet S, Harbarth S, et al. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Infection control programme. Lancet 2000;356:1307-1312.
31. Apisarnthanarak A, Pinitchai U, Thongphubeth K, Yuekyen C, Warren DK, Fraser VJ. A multifaceted intervention to reduce pandrug-resistant Acinetobacter baumannii colonization and in- fection in 3 intensive care units in a Thai tertiary care center: a 3-year study. Clin Infect Dis 2008;47:760-767.
32. Eckmanns T, Schwab F, Bessert J, et al. Hand rub consumption and hand hygiene compliance are not indicators of pathogen transmission in intensive care units. J Hosp Infect 2006;63:406-411.
33. Crivaro V, Di Popolo A, Caprio A, et al. Pseudomonas aeruginosa in a neonatal intensive care unit: molecular epidemiology and infection control measures. BMC Infect Dis 2009;9:70.
34. Pitten FA, Panzig B, Schröder G, Tietze K, Kramer A. Transmission of a multiresistant Pseudomonas aeruginosa strain at a German university hospital. J Hosp Infect 2001;47:125-130.